Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis SA’s ...

Lexicon Pharmaceuticals Inc. said March 28 it will exclusively license its drug candidate LX9851 to Danish pharmaceutical ...

Zimislecel, Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the ...

The Philippine Economic Zone Authority (PEZA) said Friday that a new ecozone in Tarlac will host the country’s first ...

Suzhou Zion Pharma Technology Co. Ltd. has identified GTPase KRAS G12D or G13D mutant and/or KRAS inhibitors reported to be useful for the treatment of cancer.

Abbisko Cayman Limited ( ($HK:2256) ) has shared an announcement. Abbisko Therapeutics announced that the Center for Drug Evaluation of the China ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Pharmaceutical companies control and hide ... Yet the manuscripts that the peer reviewers scrutinize only include limited, selected summary pieces of information rather than the full data.

Laurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of 20 stocks on the Nifty Pharma index ending lower. The pharma ...

He was associated with INTAS Pharmaceutical Laboratories Ltd as Senior Vice President operations (Site Head) since 2018. Prior to that, he was working with Dr. Reddy’s Labs as Vice President ...